相关实验视频
Updated: May 29, 2025

07:56
Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Published on: April 11, 2019
21.5K
针对多个DNAMTase活动的通用两步策略:通过CRISPR/Cas12a辅助的超分支滚动圆放大 (CA-HRCA) 增强灵敏度
Shiying Zhou1,2, Human Sun1, Liyuan Deng1
1Key Laboratory for Biorheological Science and Technology of Ministry of Education, Bioengineering College of Chongqing University, Chongqing 400044, P. R. China.
Analytical methods : advancing methods and applications
|February 7, 2025
概括
一种新的CRISPR/Cas12a辅助超分支滚动圆放大 (CA-HRCA) 方法检测了DNA甲基转移酶 (DNA MTase) 的活性. 这种快速测试显示了药物查和诊断的高灵敏度和特异性.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 酶检测 酶检测 酶检测
背景情况:
- 基因甲基转移酶 (DNA MTase) 活性对遗传性疾病至关重要,影响药物查,诊断和治疗.
- 精确检测DNAMTase活性对于推进研究和临床应用至关重要.
研究的目的:
- 开发一种通用,高效和敏感的DNA MTase活动检测策略.
- 建立一种用于药物查,临床诊断和与DNA甲基化相关的疾病治疗的新型试验.
主要方法:
- 开发了一个两步的CRISPR/Cas12a辅助超分支滚动圆放大 (CA-HRCA) 策略.
- 在第一步中,同时进行了DNA甲基化,限制酶消化和HRCA放大.
- 通过HRCA的dsDNA产品诱导的CRISPR/Cas12a附带裂变被用于第二步的信号放大.
主要成果:
- 该CA-HRCA策略成功检测了Dam MTase和M.SssI MTase,总检测时间为155分钟.
- 达到了Dam MTase的7.6 × 10-4 U mL-1的低检测极限 (LOD) 和M.SssI MTase的1.8 × 10-4 U mL-1的低检测极限.
- 通过血清增值试验和抑制剂评估证明了优异的特异性,可重复性和实际适用性.
结论:
- 拟议的CA-HRCA测定提供了一种简化和快速的方法来检测DNA MTase活动.
- 这种测试对药物开发和与DNA甲基化相关的临床诊断具有重大潜力.
- 使用dsDNA激活器可以提高CRISPR/Cas12a附带裂解效率,从而提高传感性能.
相关概念视频
Homologous Recombination
50.1K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.1K
CRISPR
49.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.1K

